<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">CardioSomatics</journal-id><journal-title-group><journal-title xml:lang="en">CardioSomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>CardioСоматика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2221-7185</issn><issn publication-format="electronic">2658-5707</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">676890</article-id><article-id pub-id-type="doi">10.17816/CS676890</article-id><article-id pub-id-type="edn">WQHNUC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Features of diagnosing postexertional malaise and chronic fatigue syndrome in the development of medical rehabilitation programs for long COVID</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности диагностики постнагрузочного недомогания и синдрома хронической усталости в разработке программ медицинской реабилитации «длительного COVID»</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2134-4107</contrib-id><contrib-id contrib-id-type="spin">8239-3942</contrib-id><name-alternatives><name xml:lang="en"><surname>Avdeeva</surname><given-names>Ksenia S.</given-names></name><name xml:lang="ru"><surname>Авдеева</surname><given-names>Ксения Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Tyumen Cardiology Research Center, MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>Тюменский кардиологический научный центр, канд. мед. наук</p></bio><email>avdeeva_03@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6251-4179</contrib-id><contrib-id contrib-id-type="spin">5896-5350</contrib-id><name-alternatives><name xml:lang="en"><surname>Petelina</surname><given-names>Tatiana I.</given-names></name><name xml:lang="ru"><surname>Петелина</surname><given-names>Татьяна Ивановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Tyumen Cardiology Research Center, MD, Dr. Sci. (Medicine), Assistant Professor</p></bio><bio xml:lang="ru"><p>Тюменский кардиологический научный центр, д-р мед. наук, доцент</p></bio><email>petelina@infarkta.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-4898-6089</contrib-id><contrib-id contrib-id-type="spin">8833-7493</contrib-id><name-alternatives><name xml:lang="en"><surname>Gorbachevskii</surname><given-names>Aleksandr V.</given-names></name><name xml:lang="ru"><surname>Горбачевский</surname><given-names>Александр Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Tyumen Cardiology Research Center</p></bio><bio xml:lang="ru"><p>Тюменский кардиологический научный центр</p></bio><email>gorbachevskyalex@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8155-3779</contrib-id><contrib-id contrib-id-type="spin">7785-7911</contrib-id><name-alternatives><name xml:lang="en"><surname>Sharoyan</surname><given-names>Yliya A.</given-names></name><name xml:lang="ru"><surname>Шароян</surname><given-names>Юлия Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Tyumen Cardiology Research Center</p></bio><bio xml:lang="ru"><p>Тюменский кардиологический научный центр</p></bio><email>SharoyanUA@infarkta.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6446-5224</contrib-id><contrib-id contrib-id-type="spin">4653-9489</contrib-id><name-alternatives><name xml:lang="en"><surname>Bessonova</surname><given-names>Marina I.</given-names></name><name xml:lang="ru"><surname>Бессонова</surname><given-names>Марина Игоревна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Tyumen Cardiology Research Center, MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>Тюменский кардиологический научный центр, канд. мед. наук</p></bio><email>bessonovami@infarkta.net</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Tomsk National Research Medical Center of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Томский национальный исследовательский медицинский центр Российской академии наук</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-07-13" publication-format="electronic"><day>13</day><month>07</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-06-11" publication-format="electronic"><day>11</day><month>06</month><year>2025</year></pub-date><volume>16</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>156</fpage><lpage>167</lpage><history><date date-type="received" iso-8601-date="2025-03-06"><day>06</day><month>03</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-06-22"><day>22</day><month>06</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ООО "Эко-Вектор"</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://cardiosomatics.ru/2221-7185/article/view/676890">https://cardiosomatics.ru/2221-7185/article/view/676890</self-uri><abstract xml:lang="en"><p>One of the key challenges in modern medical rehabilitation is the recovery of patients with symptoms of long COVID. Various types of physical exercise are considered the most effective rehabilitation methods. However, according to published data, there is a phenotype of long COVID associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), characterized by postexertional malaise and exercise intolerance. For safe medical rehabilitation, early identification of ME/CFS and the development of alternative rehabilitation programs with reduced physical exertion are required for this category of patients.</p> <p>Sources were identified through searches of electronic databases, including eLIBRARY.RU, SpringerLink, Frontiers, and PubMed.</p> <p>The clinical importance of this issue is compounded by the absence of clear diagnostic criteria and validated biomarkers for both long COVID and ME/CFS, highlighting the need for thorough phenotyping. The present review provides a detailed description of the ME/CFS phenotype and proposes a diagnostic algorithm for postexertional malaise based on the use of questionnaires, diagnostic testing, and cardiopulmonary exercise testing in patients with long COVID.</p></abstract><trans-abstract xml:lang="ru"><p>Одна из важных проблем современной медицинской реабилитации — восстановление пациентов с симптомами «длительного COVID». Наиболее эффективными методами реабилитации считаются различные виды физических упражнений. Однако, согласно данным литературы, существует фенотип «длительного COVID» с синдромом хронической усталости (СХУ), который характеризуется ухудшением состояния после физической активности и непереносимостью физической нагрузки. В целях безопасности медицинской реабилитации необходима ранняя диагностика СХУ и формирование альтернативной программы реабилитации с ограничением физической нагрузки у этой категории пациентов.</p> <p>Поиск и отбор литературных источников проводили в системе опубликованных исследований в научных базах elibrary.ru, link.springer.com, frontiersin.org, pubmed.ncbi.nlm.nih.gov и других.</p> <p>Важность проблемы усугубляется тем, что у «длительного COVID» и СХУ отсутствуют чёткие диагностические критерии и специфические биомаркёры, что делает необходимым тщательный анализ фенотипов данных заболеваний. Результат анализа литературы по этой тематике — детальное описание фенотипа СХУ, а также попытка создания оптимального алгоритма диагностики постнагрузочного недомогания с использованием диагностических тестов, опросников и кардиопульмонального нагрузочного тестирования у пациентов с «длительным COVID».</p></trans-abstract><kwd-group xml:lang="en"><kwd>long COVID</kwd><kwd>COVID-19</kwd><kwd>post-COVID syndrome</kwd><kwd>myalgic encephalomyelitis/chronic fatigue syndrome</kwd><kwd>rehabilitation</kwd><kwd>cardiopulmonary exercise testing</kwd><kwd>six-minute walk test</kwd><kwd>DePaul symptom questionnaire</kwd><kwd>Borg rating of perceived exertion scale</kwd><kwd>post-exertional malaise</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>длительный COVID</kwd><kwd>фенотипы COVID</kwd><kwd>постковидный синдром</kwd><kwd>синдром хронической усталости</kwd><kwd>медицинская реабилитация</kwd><kwd>кардиореспираторное нагрузочное тестирование</kwd><kwd>тест шестиминутной ходьбы</kwd><kwd>опросник Де Поля</kwd><kwd>шкала Борга</kwd><kwd>недомогание после физической нагрузки</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Wu K, Van Name J, Xi L. Cardiovascular abnormalities of long-COVID syndrome: Pathogenic basis and potential strategy for treatment and rehabilitation. Sports Med Health Sci. 2024;6(3):221–231. doi: 10.1016/j.smhs.2024.03.009 EDN: VQBRKB</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Soriano JB, Murthy S, Marshall JC, et al; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–e107. doi: 10.1016/S1473-3099(21)00703-9 EDN: NHYDEH</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187(20):5500–5529. doi: 10.1016/j.cell.2024.07.054</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Sharma SK, Mohan A, Upadhyay V. Long COVID syndrome: An unfolding enigma. Indian J Med Res. 2024;159(6):585–600. doi: 10.25259/IJMR_1449_23 EDN: XJHGGO</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Lenz C, Slack MPE, Shea KM, et al. Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights. Crit Rev Microbiol. 2024;50(3):315–328. doi: 10.1080/1040841X.2023.2190405</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE), 2024.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sukocheva OA, Maksoud R, Beeraka NM, et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179–196. doi: 10.1016/j.jare.2021.11.013 EDN: ZAWOUH</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Annesley SJ, Missailidis D, Heng B, et al. Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies. Trends Mol Med. 2024;30(5):443–458. doi: 10.1016/j.molmed.2024.02.003 EDN: UISEKH</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). 2023;10:1187163. doi: 10.3389/fmed.2023.1187163 EDN: OYZQXA</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Van Campen CLMC, Rowe PC, Visser FC. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina (Kaunas). 2021;58(1):28. doi: 10.3390/medicina58010028 EDN: YQFXBU</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Graves BS, Patel M, Newgent H, et al. Chronic Fatigue Syndrome: Diagnosis, Treatment, and Future Direction. Cureus. 2024;16(10):e70616. doi: 10.7759/cureus.70616 EDN: VOOZZO</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe. Medicina (Kaunas). 2021;57(5):510. doi: 10.3390/medicina57050510 EDN: JOZTQW</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Jason LA, Holtzman CS, Sunnquist M, Cotler J. The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome. J Health Psychol. 2021;26(2):238–248. doi: 10.1177/1359105318805819</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas). 2021;57(5):418. doi: 10.3390/medicina57050418</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863–876. doi: 10.1016/S2213-2600(22)00126-6 EDN: NGXAAD</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Salari N, Khodayari Y, Hosseinian-Far A, et al. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosoc Med. 2022;16(1):21. doi: 10.1186/s13030-022-00250-5</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>AlMuhaissen S, Abu Libdeh A, et al. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: is there a connection? Curr Med Res Opin. 2023;39(8):1119–1126. doi: 10.1080/03007995.2023.2242244 EDN: TDVORU</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Domingo JC, Battistini F, Cordobilla B, et al. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study. J Transl Med. 202410;22(1):343. doi: 10.1186/s12967-024-05148-0 EDN: HNHCAG</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gloeckl R, Leitl D, Schneeberger T, et al. Rehabilitative interventions in patients with persistent post COVID-19 symptoms-a review of recent advances and future perspectives. Eur Arch Psychiatry Clin Neurosci. 2024;274(8):1819–1828. doi: 10.1007/s00406-023-01631-9 EDN: OKMPBT</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Reese JT, Blau H, Casiraghi E, et al. N3C Consortium; RECOVER Consortium. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87:104413. doi: 10.1016/j.ebiom.2022.104413 EDN: VSGSQY</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Dagliati A, Strasser ZH, Hossein Abad ZS, et al. Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study. EClinicalMedicine. 2023;64:102210. doi: 10.1016/j.eclinm.2023.102210</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Kenny G, McCann K, O'Brien C, et al. All-Ireland Infectious Diseases (AIID) Cohort Study Group. Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect Dis. 2022;9(4):ofac060. doi: 10.1093/ofid/ofac060</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Bonilla H, Quach TC, Tiwari A, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bubnova MG, Shlyakhto EV, Aronov DM, et al. Coronavirus disease 2019: features of comprehensive cardiac and pulmonary rehabilitation. Russian Journal of Cardiology. 2021;26(5):4487. doi: 10.15829/1560-4071-2021-4487 EDN: GGZNWF</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Faghy MA, Dalton C, Duncan R, et al. Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID — Best practice approaches. Prog Cardiovasc Dis. 2024;83:55–61. doi: 10.1016/j.pcad.2024.02.005 EDN: XHLPSR</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Arron HE, Marsh BD, Kell DB, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease. Front Immunol. 2024;15:1386607. doi: 10.3389/fimmu.2024.1386607 EDN: CNSVHI</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Keller B, Receno CN, Franconi CJ, et al. Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations. J Transl Med. 2024;22(1):627. doi: 10.1186/s12967-024-05410-5 EDN: KGEAWW</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Molnar T, Lehoczki A, Fekete M, et al. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience. 2024;46(5):5267–5286. doi: 10.1007/s11357-024-01165-5 EDN: EVOCDQ</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Saito S, Shahbaz S, Luo X, et al. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front Immunol. 2024;15:1341843. doi: 10.3389/fimmu.2024.1341843 EDN: QTEPUG</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bizjak DA, Ohmayer B, Buhl JL, et al. Functional and Morphological Differences of Muscle Mitochondria in Chronic Fatigue Syndrome and Post-COVID Syndrome. Int J Mol Sci. 2024;25(3):1675. doi: 10.3390/ijms25031675 EDN: FKDQFM</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Chang X, Ismail NI, Rahman A, et al. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Antioxid Redox Signal. 2023;38(7-9):599–618. doi: 10.1089/ars.2022.0126 EDN: PSKITX</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Appelman B, Charlton BT, Goulding RP, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15(1):17. doi: 10.1038/s41467-023-44432-3 EDN: WYJDDU</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Scheibenbogen C, Wirth KJ. Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated Evidence. J Cachexia Sarcopenia Muscle. 2025;16(1):e13669. doi: 10.1002/jcsm.13669 EDN: ZMTIUN</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US), 2015. doi: 10.17226/19012</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>An Y, Guo Z, Fan J, et al. Prevalence and measurement of post-exertional malaise in post-acute COVID-19 syndrome: A systematic review and meta-analysis. Gen Hosp Psychiatry. 2024;91:130–142. doi: 10.1016/j.genhosppsych.2024.10.011 EDN: UPWZLW</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Moore GE, Keller BA, Stevens J, et al. Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina (Kaunas). 2023;59(3):571. doi: 10.3390/medicina59030571 EDN: RCLZUA</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Aparisi Á, Ladrón R, Ybarra-Falcón C, et al. Exercise Intolerance in Post-Acute Sequelae of COVID-19 and the Value of Cardiopulmonary Exercise Testing- a Mini-Review. Front Med (Lausanne). 2022;9:924819. doi: 10.3389/fmed.2022.924819 EDN: XOKJER</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Persiyanova-Dubrova AL, Matveeva IF, Bubnova MG. Approaches to choosing the intensity of aerobic training in cardiac rehabilitation. Profilakticheskaya meditsina. 2023;26(10):123–129. doi: 10/17116/profmed202326101123/ EDN: MXXMVV</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Joseph P, Singh I, Oliveira R, et al. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not? Chest. 2023;164(3):717–726. doi: 10.1016/j.chest.2023.03.049 EDN: NQLOXN</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Stevens S, Snell C, Stevens J, et al. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Pediatr. 2018;6:242. doi: 10.3389/fped.2018.00242</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Keller BA, Pryor JL, Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment. J Transl Med. 2014;12:104. doi: 10.1186/1479-5876-12-104 EDN: HFFHJR</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Kindlon T. Do graded activity therapies cause harm in chronic fatigue syndrome? J Health Psychol. 2017;22(9):1146–1154. doi: 10.1177/1359105317697323</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Persiyanova-Dubrova AL, Matveeva IF, Bubnova MG. Borg scale in cardiac rehabilitation: methodology and prospects for use. Rus J Prev Med. 2022;25(9):90–96. doi: 10.17116/profmed20222509190</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Bubnova MG, Persiyanova-Dubrova AL. Six-minute walk test in cardiac rehabilitation. Cardiovascular Therapy and Prevention. 2020;19(4):2561. doi: 10.15829/1728-8800-2020-2561</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Cotler J, Holtzman C, Dudun C, Jason LA. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics (Basel). 2018;8(3):66. doi: 10.3390/diagnostics8030066</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Bubnova MG, Aronov DM. Cardiac rehabilitation: stages, principles and international classification of functioning (icf). Profilakticheskaya meditsina. doi: 10.17116/profmed20202305140 EDN: UNQBDG</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Nikolaev Na, Martynov Ai, Skirdenko YuP., et al. International Declaration of Adherence to Treatment 2023 ("Omsk Declaration"): Presentation for Russian readers. Medical news of the North Caucasus. 2024;19(1):1–9. doi: 10.14300/mnnc.2024.19001 EDN: XAGYBO</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Wilshire CE, Kindlon T, Courtney R, et al. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. 2018;6(1):6. doi: 10.1186/s40359-018-0218-3 EDN: XOZRBC</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Twist FN, Maus M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinol Lett. 2009;30(3):284–299. EDN: NBCQJN</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Visseren FLJ, Mach F, Smulders YM, et al. ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. doi: 10.1093/eurheartj/ehab484 EDN: RTXKRS</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Russian Journal of Cardiology. 2022;27(7):5155. doi: 10.15829/1560-4071-2022-5155. EDN: VQDNIK</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Mathew J, Nugent K. Post-Acute Sequelae of SARS-CoV-2 Infections: Exercise Limitation and Rehabilitation. Yale J Biol Med. 2024;97(4):463–472. doi: 10.59249/NHFT4839</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Clinical management of COVID-19: Living guideline [Internet]. Geneva: World Health Organization, 2022.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>DeMars J, Brown DA, Angelidis I, et al. What is Safe Long COVID Rehabilitation? J Occup Rehabil. 2023;33(2):227–230. doi: 10.1007/s10926-022-10075-2 EDN: REJPGW</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Vink M, Vink-Niese A. The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diseases. 2023;11(1):11. doi: 10.3390/diseases11010011 EDN: YLZTEF</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Chuang HJ, Lin CW, Hsiao MY, et al. Long COVID and rehabilitation. J Formos Med Assoc. 2024;123:Suppl.1:S61–S69. doi: 10.1016/j.jfma.2023.03.022 EDN: DCFSME</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Calabrese M, Garofano M, Palumbo R, et al. Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art Life (Basel). 2021;11(3):259. doi: 10.3390/life11030259 EDN: KQCRZV</mixed-citation></ref></ref-list></back></article>
